TNGX 8-K: SEC filing

Filed with the SEC on Nov 9, 2026 · accession 0001193125-26-452635

TNGX filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Tango Therapeutics furnished a press release reporting its financial results for the quarter ended September 30, 2026, under Item 2.02 of Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantTango Therapeutics, Inc.

Chief financial officerMatthew Gall

✦ Ask GOAX AI about this filing — what it means for TNGX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TNGX?

Click here

Frequently asked questions

What did TNGX file with the SEC on Nov 9, 2026?

TNGX filed a 8-K (SEC filing). Tango Therapeutics furnished a press release reporting its financial results for the quarter ended September 30, 2026, under Item 2.02 of Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other TNGX SEC filings

Get alerts when TNGX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

TNGX overview TNGX analysis TNGX news Latest SEC filings